BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15652748)

  • 1. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
    Fernandez-Zapico ME; Gonzalez-Paz NC; Weiss E; Savoy DN; Molina JR; Fonseca R; Smyrk TC; Chari ST; Urrutia R; Billadeau DD
    Cancer Cell; 2005 Jan; 7(1):39-49. PubMed ID: 15652748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VAV1: a new target in pancreatic cancer?
    Denicola G; Tuveson DA
    Cancer Biol Ther; 2005 May; 4(5):509-11. PubMed ID: 15970675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1.
    Razidlo GL; Wang Y; Chen J; Krueger EW; Billadeau DD; McNiven MA
    Dev Cell; 2013 Mar; 24(6):573-85. PubMed ID: 23537630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1.
    Huang PH; Lu PJ; Ding LY; Chu PC; Hsu WY; Chen CS; Tsao CC; Chen BH; Lee CT; Shan YS; Chen CS
    Oncogene; 2017 Apr; 36(16):2202-2214. PubMed ID: 27893715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.
    Razidlo GL; Magnine C; Sletten AC; Hurley RM; Almada LL; Fernandez-Zapico ME; Ji B; McNiven MA
    Cancer Res; 2015 Jul; 75(14):2907-15. PubMed ID: 25977335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site.
    Kline JB; Moore DJ; Clevenger CV
    Mol Endocrinol; 2001 May; 15(5):832-41. PubMed ID: 11328862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic recruitment of PAK1 to the immunological synapse is mediated by PIX independently of SLP-76 and Vav1.
    Phee H; Abraham RT; Weiss A
    Nat Immunol; 2005 Jun; 6(6):608-17. PubMed ID: 15864311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vav-family proteins in T-cell signalling.
    Tybulewicz VL
    Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of p21-activated kinase-independent Rac1 signal transduction by nischarin.
    Reddig PJ; Xu D; Juliano RL
    J Biol Chem; 2005 Sep; 280(35):30994-1002. PubMed ID: 16002401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
    Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
    J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
    Heider TR; Lyman S; Schoonhoven R; Behrns KE
    Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter.
    Cai D; Iyer A; Felekkis KN; Near RI; Luo Z; Chernoff J; Albanese C; Pestell RG; Lerner A
    Cancer Res; 2003 Oct; 63(20):6802-8. PubMed ID: 14583477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
    Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
    Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of Sam68 with Vav1 contributes to tumorigenesis.
    Lazer G; Pe'er L; Schapira V; Richard S; Katzav S
    Cell Signal; 2007 Dec; 19(12):2479-86. PubMed ID: 17855053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remedial strategies in structural proteomics: expression, purification, and crystallization of the Vav1/Rac1 complex.
    Brooun A; Foster SA; Chrencik JE; Chien EY; Kolatkar AR; Streiff M; Ramage P; Widmer H; Weckbecker G; Kuhn P
    Protein Expr Purif; 2007 May; 53(1):51-62. PubMed ID: 17275330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147 inhibits the nuclear factor of activated T-cells by impairing Vav1 and Rac1 downstream signaling.
    Ruiz S; Castro-Castro A; Bustelo XR
    J Biol Chem; 2008 Feb; 283(9):5554-66. PubMed ID: 18160397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
    Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE
    Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.
    Mirza AM; Gysin S; Malek N; Nakayama K; Roberts JM; McMahon M
    Mol Cell Biol; 2004 Dec; 24(24):10868-81. PubMed ID: 15572689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
    Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
    Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.